•
NA
Noubar Afeyan
Founder of Indigo
Cambridge, Massachusetts
Overview
Noubar Afeyan is the Founder & CEO of Flagship Pioneering and Co-founder & Chairman of Moderna. His notable career highlights include founding successful biotech companies like Moderna Therapeutics and serving on the Executive Committee of Massachusetts Institute of Technology (MIT).
Currently, Noubar Afeyan leads Flagship Pioneering, a renowned venture capital firm, and has played a pivotal role in the success and growth of Moderna, a groundbreaking biotechnology company.
Work Experience
Founder and CEO
2000 - Current
Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. To date, Flagship has deployed over $3.4 billion in capital toward the founding and growth of its pioneering companies alongside more than $26 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 40 companies, including Denali Therapeutics (NASDAQ: DNLI), Foghorn Therapeutics (NASDAQ: FHTX), Generate:Biomedicines, Inari, Indigo Agriculture, Moderna (NASDAQ: MRNA), Omega Therapeutics (NASDAQ: OMGA), Sana Biotechnology (NASDAQ: SANA), Seres Therapeutics (NASDAQ: MCRB) and Tessera Therapeutics.
Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Member of Executive Committee, MIT Corporation
2016
Co-Founder and Chairman
2010
Co-Founder and Chairman
2018
Co-Founder and Board Member
2018
Tessera Therapeutics is a biotechnology company that focuses on a new category of genetic medicines.
Raised $531,755,224.00 from Longevity Vision Fund, SALT Fund, Hanwha Impact Partners, March Capital, Alaska Permanent Fund, Cormorant Asset Management, Altitude Life Science Ventures, SoftBank Vision Fund, Flagship Pioneering and Artis Ventures (AV).
Co-Founder and Board Member
2024
Indigo is an agricultural technology company that focuses on improving sustainability and profitability in farming practices.
Raised $1,439,000,000.00 from State of Michigan Retirement System, Lingotto, Flagship Pioneering and Timon Capital.
Co-Founder and Chairman
2021
Apriori Bio offers a platform for creating variant-resilient vaccines and provides real-time insights to prepare for future outbreaks.
Raised $51,100,000.00 from Coalition for Epidemic Preparedness Innovations.
Co-founder and Chairman
2022
Founding Chairman
2021
Co-Founder and Board Member
2014
Aurora Prize for Awakening Humanity is an annual international humanitarian award, which is initiated to recognize and express gratitude to those courageous individuals or organizations that impact on preserving human life and advancing humanitarian causes. It is awarded on behalf of the survivors of the Armenian Genocide and in gratitude to their saviors. The Aurora Prize ceremonies take place annually in Yerevan, Armenia starting from 24 April 2016. The laureate of the prize receives $100,000 grant as well as the opportunity to nominate organizations that inspired his or her work for a US $1,000,000 award (from Wikipedia).
Education
Investments
Latest Articles
•
Ray Dalio on Investing, Management, and the Changing World Order (Ep. 138)
Talks about Economics, Podcast and Tyler Cowen
•
David Rubenstein on Private Equity, Public Art, and Philanthropy (Ep. 136)
Talks about Podcast, Tyler Cowen and Economics
•
David Salle on the Experience of Art (Ep. 135)
Talks about Economics, Tyler Cowen and Art